1-180230409-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_033343.4(LHX4):c.-121T>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000519 in 848,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000026 ( 0 hom. )
Consequence
LHX4
NM_033343.4 5_prime_UTR_premature_start_codon_gain
NM_033343.4 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0670
Genes affected
LHX4 (HGNC:21734): (LIM homeobox 4) This gene encodes a member of a large protein family which contains the LIM domain, a unique cysteine-rich zinc-binding domain. The encoded protein is a transcription factor involved in the control of differentiation and development of the pituitary gland. Mutations in this gene cause combined pituitary hormone deficiency 4. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000172 (26/151496) while in subpopulation AFR AF= 0.000582 (24/41272). AF 95% confidence interval is 0.000401. There are 0 homozygotes in gnomad4. There are 15 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 26 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHX4 | NM_033343.4 | c.-121T>G | 5_prime_UTR_premature_start_codon_gain_variant | 1/6 | ENST00000263726.4 | NP_203129.1 | ||
LHX4 | NM_033343.4 | c.-121T>G | 5_prime_UTR_variant | 1/6 | ENST00000263726.4 | NP_203129.1 | ||
LHX4 | XM_011510105.3 | c.-108+1496T>G | intron_variant | XP_011508407.1 | ||||
LHX4 | XM_011510106.4 | c.-108+1256T>G | intron_variant | XP_011508408.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHX4 | ENST00000263726 | c.-121T>G | 5_prime_UTR_premature_start_codon_gain_variant | 1/6 | 1 | NM_033343.4 | ENSP00000263726.2 | |||
LHX4 | ENST00000263726 | c.-121T>G | 5_prime_UTR_variant | 1/6 | 1 | NM_033343.4 | ENSP00000263726.2 | |||
LHX4 | ENST00000558139.1 | n.112T>G | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000172 AC: 26AN: 151386Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
26
AN:
151386
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000258 AC: 18AN: 696792Hom.: 0 Cov.: 9 AF XY: 0.0000218 AC XY: 8AN XY: 367322
GnomAD4 exome
AF:
AC:
18
AN:
696792
Hom.:
Cov.:
9
AF XY:
AC XY:
8
AN XY:
367322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000172 AC: 26AN: 151496Hom.: 0 Cov.: 31 AF XY: 0.000203 AC XY: 15AN XY: 74012
GnomAD4 genome
AF:
AC:
26
AN:
151496
Hom.:
Cov.:
31
AF XY:
AC XY:
15
AN XY:
74012
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Short stature-pituitary and cerebellar defects-small sella turcica syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at